Projected Growth of the Global Autoimmune Treatment Market to USD 321.95 Billion by 2034#None#Personalized_Medicine#Biologics#Autoimmune_Therapy
Projected Growth of the Global Autoimmune Treatment Market to USD 321.95 Billion by 2034
The global autoimmune treatment market is anticipated to increase significantly, reaching USD 321.95 billion by 2034, driven by disease prevalence and innovative therapies.
third-news.com
September 25, 2026 at 12:11 AM
Projected Growth of the Global Autoimmune Treatment Market to USD 321.95 Billion by 2034#None#Personalized_Medicine#Biologics#Autoimmune_Therapy
Orna Therapeutics to Showcase In Vivo CAR Therapy at ACR Annual Meeting#United_States#Chicago#Orna_Therapeutics#CAR_therapy#Autoimmune_Therapy
Orna Therapeutics to Showcase In Vivo CAR Therapy at ACR Annual Meeting
Orna Therapeutics will highlight its innovative in vivo CAR therapy approach for autoimmune diseases at the upcoming ACR Annual Meeting in Chicago.
third-news.com
October 24, 2025 at 12:09 PM
Orna Therapeutics to Showcase In Vivo CAR Therapy at ACR Annual Meeting#United_States#Chicago#Orna_Therapeutics#CAR_therapy#Autoimmune_Therapy
AbelZeta to Present Innovative Biopharmaceutical Research at LUPUS 2025 Congress#Canada#Toronto#AbelZeta_Pharma#C-CAR168#Autoimmune_Therapy
AbelZeta to Present Innovative Biopharmaceutical Research at LUPUS 2025 Congress
AbelZeta Pharma is set to showcase their groundbreaking C-CAR168 therapy at LUPUS 2025, targeting autoimmune diseases. Join us in Toronto!
third-news.com
May 16, 2025 at 1:13 PM
AbelZeta to Present Innovative Biopharmaceutical Research at LUPUS 2025 Congress#Canada#Toronto#AbelZeta_Pharma#C-CAR168#Autoimmune_Therapy